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Cellular heterogeneity presents an important challenge to the development of cell-based therapies where there is a fundamental
requirement for predictable and reproducible outcomes. Transplanted Dental Pulp Stem/Progenitor Cells (DPSCs) have
demonstrated early promise in experimental models of spinal cord injury and stroke, despite limited evidence of neuronal and glial-
like differentiation after transplantation. Here, we report, for the first time, on the ability of single cell-derived clonal cultures of
murine DPSCs to differentiate in vitro into immature neuronal-like and oligodendrocyte-like cells. Importantly, only DPSC clones
with high nestin mRNA expression levels were found to successfully differentiate into Map2 and NF-positive neuronal-like cells.
Neuronally differentiated DPSCs possessed a membrane capacitance comparable with primary cultured striatal neurons and small
inward voltage-activated K+ but not outward Na+ currents were recorded suggesting a functionally immature phenotype. Similarly,
only high nestin-expressing clones demonstrated the ability to adopt Olig1, Olig2, and MBP-positive immature oligodendrocyte-
like phenotype. Together, these results demonstrate that appropriate markers may be used to provide an early indication of the
suitability of a cell population for purposes where differentiation into a specific lineage may be beneficial and highlight that further
understanding of heterogeneity within mixed cellular populations is required.
1. Introduction
Stem cell heterogeneity poses a significant obstacle to the
clinical implementation of cell-based therapies. Mixed cul-
tures may contain a combination of stem cells with a broad
range of differentiation potentials and long term proliferative
abilities, as well as more lineage-committed progenitor cells.
Such variability amongst cells in the same transplantable
population can lead to the adoption of adverse phenotypes,
potentially limiting improvements in outcome.
Dental Pulp Stem/Progenitor Cells (DPSCs) possess typi-
cal mesenchymal progenitor properties in vitro, demonstrat-
ing the ability to differentiate into odontoblasts/osteoblasts,
adipocytes, and chondrocytes [1–3]. Furthermore, endothe-
lial, myogenic, hepatocytic, and melanocytic differentiation
capabilities have also been reported, suggesting a diverse
range of potential therapeutic applications [4–8]. However,
DPSCs represent a highly heterogeneous population of cells
with distinct clonal differences in proliferation and min-
eralisation capabilities [1, 9]. Such variability could poten-
tially hinder progress in the development of DPSC-based
treatments. Nevertheless, transplanted mixed populations of
DPSCs have demonstrated promise at improving functional
outcome in experimentalmodels of spinal cord injury, stroke,
and Parkinson’s disease [10–15]. These effects are mostly
protective and mediated through the release of supportive
growth factors. It is, as yet, unclear whether DPSCs can
differentiate into, and functionally compensate for, neuronal
and glial cell types after transplantation. In vitro studies
have indicated potential for rodent and human DPSCs
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to differentiate into neuronal-like cells [16]. Furthermore,
independent studies have described a degree of functionality
of such neuronally differentiated DPSCs [17–21]. However,
only a small fraction of cells within such cultures develop
a functional phenotype [18]. Similarly, outcomes may differ
between patient samples subjected to the same differen-
tiation protocol [22]. Understanding the cellular biology
behind such heterogeneity poses a substantial challenge to
researchers. The identification of an appropriate marker of
neural differentiation capabilities, for which to screen DPSC
cultures beforehand, could help to minimise such variability
between studies resulting in more defined and predictable
outcomes.
In this study, single cell-derived clonal populations of
murine DPSCs (mDPSCs) were isolated and differences in
the expression of early stage neural markers identified. Only
clones with high levels of nestin expression were found to dif-
ferentiate into immature neuronal-like cells, displayingmini-
mal electrical activity. Similarly, a novel differentiation proto-
col was developed for the derivation of oligodendrocyte-like
cells from high nestin-expressing mDPSC clones. Together,
these findings suggest that nestinmay act as a suitablemarker
for use in assessing the ability of mDPSCs to differentiate into
neuronal-like and glial-like cells in vitro.
2. Experimental Procedures
2.1. Isolation of mDPSCs. All procedures were approved
by the Cardiff University Biological Standards Office. For
each DPSC isolation, the incisor pulpal tissue of 4-5 ×
21–28-day-old C57/Bl6 mice, sacrificed by CO
2
asphyxia-
tion in accordance with Schedule 1 of the UK Animals
(Scientific Procedures) Act 1986, was pooled. Following
collagenase/dispase digestion to a cellular suspension, the
preferential adherence to fibronectin selection technique was
used to select for progenitor cells by isolating cells of more
immature phenotypes based on 𝛽1 integrin functionality [23,
24]. After 12 days of primary culture, individual colonies of
fibronectin-adherent cells, displaying typical DPSC bipolar
fibroblastic-like morphology and numbering greater than
32 cells, were selected for clonal isolation and expansion
as described previously using cloning rings [25]. Clonal
DPSCswere subsequently expanded in𝛼MEMsupplemented
with 100 units/mL penicillin, 100𝜇g/mL streptomycin, and
20% (v/v) heat-inactivated foetal bovine serum (all from
Life Technologies) and 100 𝜇M l-ascorbic acid 2-phosphate
(Sigma-Aldrich). Cell counts were performed at every pas-
sage and used to track population doublings over time in
culture:
Population doublings =
log
10
(cell count at passage) − log
10
(no. of cells initially seeded)
log
10
(2)
. (1)
Cells of between 20 and 40 population doublings were
used for all experiments. Four individual mDPSC clones
that expanded sufficiently to allow multiple reproducible
differentiation experiments were used in this study, each
derived from a separate pulpal extraction (𝑛 = 4).
2.2. Neuronal Differentiation. mDPSC clones were seeded
at 10,000 cells/cm2 on poly-d-lysine/laminin-coated culture
surfaces in DMEM/F12 (1 : 1) containing L-glutamine and
HEPES buffer, 100 units/mL penicillin, 100 𝜇g/mL strepto-
mycin, and 1 × N2 supplement (all from Life Technologies),
1 × NEAA (Sigma-Aldrich), and 20 ng/mL basic fibrob-
last growth factor (bFGF) and 20 ng/mL epidermal growth
factor (both from Peprotech). After 5 days, cultures were
washed with PBS and changed to neurobasal medium sup-
plemented with 100 units/mL penicillin, 100𝜇g/mL strepto-
mycin, and 2mM L-glutamine (all from Life Technologies), 1
× NEAA (Sigma-Aldrich), and 10 ng/mL brain-derived neu-
rotrophic factor, 10 ng/mL nerve growth factor, and 10 ng/mL
neurotrophin-3 (all from Peprotech). RNA was extracted on
days 0, 5, 10, and 15 of differentiation for use in qPCR and cells
were fixed on day 15 for immunocytochemistry.
2.3. Oligodendrocyte Differentiation. Clonal mDPSC cultures
were seeded at 10,000 cells/cm2 on poly-d-lysine-coated
culture surfaces in DMEM containing 100 units/mL peni-
cillin, 100 𝜇g/mL streptomycin, SATO supplement (16 𝜇g/mL
putrescine, 62 ng/mL progesterone, 5 ng/mL sodium selenite,
and 100 𝜇g/mL bovine serum albumin (BSA)), 50 𝜇g/mL
holo-Transferrin, and 5 𝜇g/mL insulin (all from Sigma-
Aldrich) and 10 ng/mL platelet-derived growth factor-aa and
20 ng/mL bFGF (both Peprotech). After 10 days differentia-
tion cells were fixed for immunocytochemistry.
2.4. Isolation of mSTM Neurons. Mouse striatal (mSTM)
neuronal tissues were dissected in PBS from P0 mice,
digested using Accutase, and plated on poly-l-lysine-coated
glass coverslips inAdvancedDMEM/F-12 supplementedwith
2mML-glutamine, 100 units/mL penicillin, 100 𝜇g/mL strep-
tomycin, 1.8mMCaCl
2
, 0.5mM/L valproic acid, and 1 x B27-
supplement (without vitaminA) (all from Life Technologies).
2.5. Reverse Transcriptase PCR. Total RNA was extracted
using an RNeasy Mini Kit with on-column DNase digestion
(QIAGEN) according tomanufacturer’s directions and cDNA
synthesised using MMLV reverse transcriptase (Promega).
PCR reactions were performed using GoTaq Polymerase
(Promega) and product-specific primers (Supplemental Table
1 in Supplementary Material available online at http://dx.doi
.org/10.1155/2016/1290561). RNA extracted from primary cul-
tured E14.5 cortical neural stem cells, isolated as described
previously [26], was used as a positive control.
2.6. Real Time Quantitative PCR. For qPCR readings, cDNA
samples generated from three separate experiments per clone
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were used (𝑛 = 3) and each was measured in triplicate
using an ABI Prism 7000 machine (Advanced Biosystems).
Target-specific primers (Supplemental Table 2) were added
to each cDNA sample together with Precision MasterMix
with ROX and SYBRgreen (PrimerDesign). Dissociation
curves were recorded to check for specificity of reactions and
products were electrophoresed on 1.4% agarose gels in order
to confirm product size. Relative changes in expression were
calculated using the 2−ΔΔCT method [27]. Statistical analyses
were performed using Graphpad Prism Software.
2.7. Immunocytochemistry. Cells were fixed with 4% (w/v)
paraformaldehyde for 15min at room temperature and
permeabilised in 0.1% (v/v) Triton X-100 for 10min. Nonspe-
cific antibody binding was blocked by incubating in 2% (w/v)
BSA for 30min. Cells were incubated overnight with the
following primary antibodies: nestin (Santa Cruz), musashi
(Life Technologies), microtubule-associated protein 2 (Map2
(Millipore)), neurofilament light chain NF-l (Abcam), Olig1
and Olig2 (both from Millipore), myelin basic protein (MBP
(Abcam)), and 𝛽-actin (Cell Signalling). On the following
day, complementary Alexa Fluor 488- and 594-conjugated
secondary antibodies (Life Technologies) were applied. Glass
coverslips were mounted using mounting media supple-
mented with DAPI stain (VectorLabs) and preparations
imaged under a fluorescent microscope.
2.8. PatchClampElectrophysiological Recordings. Transmem-
brane currents of primary culturedmSTMneurons fromdays
3 to 21 of culture and mDPSCs neuronally differentiated for
15 days were recorded in conventional whole-cell configura-
tion. The bath solution contained 135mM NaCl, 5mM KCl,
1.2mMMgCl
2
, 1.25mM CaCl
2
, 10mM d-glucose, and 5mM
HEPES; pH was adjusted to 7.4 using NaOH. The pipette
solution contained 117mM KCl, 10mM NaCl, 2mM MgCl
2
,
1 mM CaCl
2
, 2mM Na
2
ATP, 1mM Na
2
GTP, 11mM HEPES,
and 11mM ethylene glycol tetra acetic acid; free [Ca2+]
𝑖
was
adjusted to 100 nM; pH was adjusted to 7.2 with KOH. All
recordings were performed at room temperature (22 ± 0.5∘C)
using an Axopatch 200B amplifier and Digidata 1320A/D
interface (Axon Instruments). Holding voltages were set
to −70mV and transmembrane currents recorded using a
voltage step protocol of 80ms duration in voltage range from
−120 to +80mV. Series resistance and membrane capacitance
were compensated ≈90%. Pipette resistances were ≈5–10MΩ
when filled with the pipette solution. All recordings were
filtered with an 8-pole Bessel filter at 5 kHz and digitized at
10 kHz. Tetraethylammonium chloride (TEA) was purchased
from Sigma.
2.9. Data Analysis. The patch clamp data were analyzed
using Clampfit 9.0,MicrosoftOffice Excel 2003, andMicrocal
Origin 6.0 software. Transient inward Na+ currents were
presented as peak values whereas outward steady-state K+
currents were presented as means. Current densities (pA/pF)
were plotted against command voltage (mV). Statistical com-
parisons of the means were performed using independent 𝑡-
test; differences were considered significant at 𝑝 < 0.05.
3. Results
3.1. Isolation, Expansion, and Characterisation of Clonal
mDPSC Cultures. Dental pulp cells were successfully iso-
lated and cultured from murine incisors. One day follow-
ing isolation, sparsely distributed fibroblastic-like cells were
identified growing on fibronectin-coated culture surfaces. A
number of these rapidly expanded clonally to form discrete
individual colonies. Clones were isolated at day 12 and
found to expand over extended periods, some reaching
50+ population doublings, confirming a highly proliferative
phenotype (Figure 1(a)). Presence of the neural progenitor
markers nestin and musashi was identified within expanding
clones using immunocytochemistry (Figure 1(b)). RNA was
extracted fromeach clone between 20 and 40population dou-
blings and used in RT-PCR to identify further similarities in
marker expression between four mDPSC clones and primary
cultured murine neural stem cells (mNSCs) (Figure 1(c)).
mDPSC clones were found to express a range of transcripts
also expressed byNSCs includingCD90, SCA1, GLAST, Sox2,
Pax6, Myt1l, P75, BLBP, musashi, and NF-l. However, marked
clonal differences were observed, with only the general stem
cell marker SCA1, the neural crest-associated marker P75,
and the radial glial protein BLBP being expressed by all
mDPSC clones tested. No expression of CD133 was found
in any mDPSC clone. Furthermore, clonal differences were
identified in themRNAexpression levels of nestin. Based on a
semiquantitative analysis, 8 out of 11 isolated clones appeared
to express nestin mRNA transcripts at higher levels than the
remaining 3 clones.However, only 4 of these clones continued
to expand to allow the extraction of further RNA samples for
a more accurate quantification of nestin expression and thus
are subsequently described in this study. qPCR identified that
clone 1 and clone 2 each expressed significantly higher levels
(𝑝 < 0.01) of nestin transcripts than both clone 3 and clone
4 (Figure 1(d)). Subsequently, clones 1 and 2 were defined
as high nestin-expressing clones and clones 3 and 4 as low
nestin-expressing clones.
3.2. Neuronal-Like Differentiation. mDPSCs were typically
bi/tripolar and fibroblastic-like inmorphology prior to differ-
entiation. Following 15 days of differentiation, clones initially
identified as having high levels of nestin mRNA expres-
sion adopted a more neuronal-like phenotype with multiple
neurite-like extensions. Conversely, no significant changes
in morphology were observed in low nestin-expressing
clones (Figure 2(a)). Immunocytochemical staining of the
mature neuronal proteins Map2 and NF-l was identified in
high, but not low, nestin-expressing mDPSC clones after
15 days of differentiation (Figure 2(b)). Changes in the
mRNA expression of early and mature neuronal markers
by high nestin-expressing clones over 15 days of differen-
tiation were analyzed using qPCR (Figure 2(c)). By day 5
of differentiation, mRNA expression of SCA1 was strongly
downregulated suggesting a transition from the default mes-
enchymal phenotype associated with mDPSCs. From day
5 onwards, after transferring to the neutrophin-containing
maturation medium, expression of nestin and Map2 was
seen to increase, indicating a more neuronal-like phenotype.
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Figure 1: In vitro expansion and heterogeneity in the expression of developmental markers by clonal mDPSC cultures. (a) Single cell-
derived clones, each expanded from a separate pulpal extraction, proliferated steadily for up to 240 days of culture reaching 50+ population
doublings (𝑛 = 4 clones). Traces represent continuous culture growth from day of primary isolation, and cryopreserved cells continued to
proliferate beyond the population doublings indicated. (b) Double immunostaining of clonal cultures for neural progenitor markers nestin
and musashi. (c) RNA extracted from each clone between 20 and 40 population doublings was used in RT-PCR to identify clonal differences
in the expression of RNA transcripts for CD90, stem cell antigen 1 (SCA1), glutamate aspartate transporter (GLAST), Sox2, Pax6, myelin
transcription factor 1-like (Myt1l), P75, musashi, neurofilament light chain (NF-l), and CD133. (d) qPCR analysis of nestin mRNA expression
by four mDPSC clones. Clones 1 and 2 were each individually found to express significantly higher levels of nestin than both clones 3 and 4.
DPSC cultures were subsequently divided into strongly nestin-positive clones (clone 1 and clone 2) and weakly nestin-positive clones (clone
3 and clone 4). Nestin expression was calculated as a relative percentage of GAPDH ± SEM using the 2−ΔΔCT method (𝑛 = 3, RNA samples
extracted from three separate passages per clone between 16 and 40 population doublings). One-way ANOVA with Tukey-Kramer posttest:
n.s. = not significant, ∗∗𝑝 < 0.01. Scale bars = 100𝜇m.
mRNAexpression levels forNF-lwere found to be unchanged
during the 15 days of differentiation.
Patch clamp recordings were taken to characterise the
electrophysiological properties of high nestin-expressing
mDPSC clones prior to, and after, 15 days of differentiation.
Primary cultured mSTM neurons provided a positive control
for comparison purposes. Only outward K+ currents were
detected in mDPSCs, both before and after differentiation.
These currents were effectively inhibited with 1mM TEA,
a nonselective blocker of K+ channels (Figures 3(a) and
3(b)). At the same time, both voltage-activated K+ and Na+
currents were recorded in P0 mSTM neurons (Figure 3(c)).
At a voltage of +80mV, significantly higher K+ current
densities were recorded in P0 mSTM neurons (155.4 ±
10.1 pA/pF) compared to undifferentiated (6.4 ± 1.5 pA/pF)
and neuronally differentiated mDPSCs (7.3 ± 1.4 pA/pF):
𝑝 < 3.0𝐸 − 13 and 𝑝 < 6.0𝐸 − 15, respectively. No
significant differencewas found between the current densities
of undifferentiated and neuronally differentiated mDPSCs;
however, membrane capacitance varied dramatically (Fig-
ure 3(d)). Differentiated mDPSCs (30.7 ± 4.0) possessed
statistically significant lower membrane capacitances than
undifferentiated mDPSCs (62.0 ± 10.2): 𝑝 < 0.005. This
lower capacitance was directly comparable with p0 mSTM
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Figure 2: Only high nestin-expressing mDPSC clones possess the ability to differentiate into neuronal-like cells. (a) Representative phase
contrast images of high (clone 2) and low (clone 3) nestin-expressing clones prior to and following 15 days of neuronal differentiation
demonstrating a more neuronal-like morphology in high nestin-expressing clones with small refractive cell somas extending multiple
interconnecting processes. (b) Immunocytochemical staining identified the presence of microtubule-associated protein 2 (Map2) and NF-
l in high, but not low, nestin-expressing mDPSC clones following 15 days of neuronal differentiation. (c) Changes in mRNA expression
of mesenchymal and neural markers during neuronal differentiation of high nestin-expressing mDPSC clones (clone 2). Expression levels
of target genes were normalized against GAPDH and the 2−ΔΔCT method for qPCR analysis used to calculate fold change in expression
relative to predifferentiation cells on day 0 ± SEM (𝑛 = 3 independent differentiation experiments). One-way ANOVAwith Dunnett multiple
comparisons posttest to identify significant increases/decreases in expression compared to day 0 cells: ∗𝑝 < 0.05 and ∗∗𝑝 < 0.01. Scale bars
= 100 𝜇m.
neurons (20.9 ± 6.6), with no significant difference observed
(𝑝 > 0.2). Together, these results suggest that, despite
appropriate morphology, the presence of mature neuronal
proteins after 15 days of differentiation, and a comparable
cell capacitance to primary cultured neurons, high nestin-
expressingmDPSC clonesmaintain an electrophysiologically
immature phenotype.
3.3. Oligodendrocyte-Like Differentiation. Following 10 days
of differentiation, clones with initially high levels of nestin
were seen to adopt a highly branched oligodendrocyte-
like morphology. Although some branching was observed,
low nestin-expressing clones largely failed to survive 10
days of differentiation (Figure 4(a)). Immunocytochemical
staining of myelin basic protein (MBP), Olig1, and Olig2
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Figure 3: Neuronally differentiated high nestin-expressing mDPSCs show immature electrophysiology properties. Current density-voltage
relationships of transmembrane K+ currents of undifferentiated (a) and neuronally differentiated (b) high nestin-expressing mDPSCs (clone
2) in the absence (I, inlet 1 illustrates exemplar trace of currents, 𝑛 = 14 and 17 cells, resp.) and presence of TEA (1mM) (◼, inlet 2 illustrates
exemplar trace of currents, 𝑛 = 9 for each differentiation condition). (c) Current density-voltage relationships of transmembrane K+ current
(I) and Na+ currents (󳶃) of mSTM neurons (𝑛 = 23 cells). Inlet illustrates exemplar trace of currents. The mean ± SEM current densities
at +80mV of undifferentiated (6.4 ± 1.5 pA/pF) and neuronally differentiated mDPSCs (7.3 ± 1.4 pA/pF) showed a significant difference in
comparison with primary cultured mSTM neurons (155.4 ± 10.1 pA/pF): 𝑝 < 3.0𝐸 − 13 and 𝑝 < 6.0𝐸 − 15, respectively. (d) Comparison
of capacitances of all three cell types. The mean values ± SEM (◻) of undifferentiated mDPSCs (62.0 ± 10.2) and neuronally differentiated
high nestin-expressing mDPSCs (30.7 ± 4.0), as well as undifferentiated mDPSCs and P0 mSTM neurons (20.9 ± 6.6), were considered as
significantly different: 𝑝 < 0.005 and 𝑝 < 0.002, respectively. e and I are maximal and minimal values, respectively.
was only observed in high nestin-expressing mDPSC clones
(Figure 4(b)). The expression of oligodendrocyte-associated
proteins, togetherwith appropriatemorphology, suggests that
this novel protocolmay be used to derive an oligodendrocyte-
like phenotype from mDPSCs with high levels of nestin
expression.
4. Discussion
In this study we have identified heterogeneity in the ability of
single cell-derived clonal cultures of mDPSCs to differentiate
into neuronal-like and glial-like cells.Those clones possessing
the highest levels of mRNA expression for the neuronal
progenitor-associated intermediate filament protein, nestin,
showed a greater potential for differentiation down both
neural lineages. Although some evidence of variability in
the neural differentiation potential of heterogeneous DPSC
has been previously described [18, 22], our findings sug-
gest that nestin may act as a suitable marker for which
to screen DPSC cultures in vitro prior to use in neural
tissue engineering applications.The problems associatedwith
cellular heterogeneity are increasingly becoming recognised
in the stem cell research field and gaining a fuller under-
standing of the variability within transplantable populations
will help maximise the potential of any stem cell-based
therapy.
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Figure 4: Only high nestin-expressing mDPSC clones display the ability to differentiate into oligodendrocyte-like cells. (a) Representative
phase contrast images of high (clone 2) and low (clone 3) nestin-expressing clones following 15 days of oligodendrocyte-like differentiation.
Clones with higher levels of nestin mRNAwere found to adopt a more highly branched oligodendrocyte-like morphology compared to lower
nestin-expressing clones. (b) Immunocytochemical staining identified the presence of myelin basic protein (MBP) and the oligodendrocyte
transcription factors Olig1 and Olig2 in high, but not low, nestin-expressing mDPSC clones following 10 days of differentiation. 𝛽-actin
staining was performed to demonstrate highly branched morphology. Scale bars = 100 𝜇m.
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Prior to differentiation, the expression of a range of
developmental and neural progenitor markers by single
cell-derived mDPSC cultures was extensively analyzed and
compared with primary mNSCs. Although mDPSCs were
found to express a number of markers also associated with
NSCs including Sox2, Pax6, GLAST, BLBP, nestin, and NF-
l, expression patterns were highly variable between clones,
demonstrating the degree of heterogeneity that exists within
the mixed populations of DPSCs typically used for neu-
ral transplantation studies [10–15]. Importantly, only those
clones identified with high levels of nestin mRNA expres-
sion displayed the ability to differentiate into a neuronal-
like phenotype based on cell morphology and increased
expression levels of the more mature neuronal marker Map2.
To test the electrophysiological properties of these cells,
patch clamp recordings were made. The electrical properties
of neuronal-like cells derived from murine DPSCs remain
largely uncharacterised in contrast to humanDPSCs inwhich
voltage-activated Na+ and K+ currents and ATP-activated
Ca2+ surges have been recorded [17, 18, 20, 21]. In the
only previous functional study using rodent DPSCs, mixed
populations of mDPSCs differentiated using an established
protocol displayed voltage-activated Ca2+ but not K+ or Na+
currents, directly contradicting recordings taken when the
same protocol was applied to human hDPSCs [18, 19]. Single
cell-derived cultures of high nestin-expressing mDPSCs dif-
ferentiated using the protocol described in this report, on the
other hand, display TEA-sensitive voltage-gated K+ currents,
demonstrating the presence of functional voltage-activated
K+ channels in neuronally differentiated rodent DPSCs for
the first time. Although the amplitude of these currents is
reduced when compared to mSTM neurons, similar mem-
brane capacitances were measured for each cell type. This
reduction in capacitance is indicative of cells with an ability
to store electrical charge directly comparable to primary
cultured striatal neurons, confirming a more neuronal-like
phenotype after differentiation. Although a fully functional
phenotype with the ability to fire action potentials has yet
to be derived from either human or rodent DPSCs, there is
sufficient evidence here to suggest that high nestin-expressing
mDPSCs may be promoted to differentiate, at least partially,
along this lineage. However, further steps will be required to
obtain a more mature neuronal-like phenotype and future
studies might focus on incorporating a supporting cell type
in coculture to provide appropriate trophic factor support for
the development andmaturation of functional properties, for
example, astrocytes [28, 29].
Oligodendrocyte-like differentiation of DPSCs has only
previously been described in vivo, following mixed pop-
ulation transplantation into a rat model of spinal cord
injury [12]. Using a novel protocol adapted from those
used in the culture and differentiation of oligodendro-
cyte progenitor cells (OPCs) [30, 31], mDPSC clones with
high levels of nestin mRNA expression adopted a highly
branched oligodendrocyte-like morphology and stained pos-
itive for oligodendrocyte markers Olig1, Olig2, and MBP.
Despite the expression of MBP in differentiated mDPSCs,
there was no observation of membranous sheets associated
with mature myelinating oligodendrocytes in vitro [30, 32].
This suggests that, similar to neuronal differentiation, high
nestin-expressing mDPSCs are able to differentiate partially
to an immature premyelinating phenotype, but further
differentiation steps may be required for full functionality.
Nevertheless, the development of this protocol represents a
significant finding and may provide a useful in vitro research
tool for further studies into mechanisms through which
DPSCs may promote central nervous system repair and
regeneration.
Unlike bone marrow, another common source of mes-
enchymal stem cells, dental pulp is a nonhaematopoetic tissue
and clonal DPSC cultures may be more lineage-restricted in
nature [9]. Their highly heterogeneous nature is purported
to be attributable to multiple populations of progenitor cells
residing in different locations of the pulp which may possess
different proliferative and differentiation capabilities. Differ-
ent niches have been identified in situ associated with the
vasculature, within the pulpal stroma, in the subodontoblast
layer and amongst peripheral nerve-associated glial cells [33–
38].During development, the dental pulp and central nervous
system both derive from the embryonic ectoderm. Following
neurulation,multipotent neural crest cells migrate away from
the neural tube into developing craniofacial tissues. At the
initiation of tooth morphogenesis, these cells populate the
underlyingmesenchyme, eventually giving rise to the cellular
components of pulpal tissue [39]. Multipotent adult DPSCs
that maintain neural crest stem cell characteristics and may
represent a source of cells with greater potential for neuronal
and glial differentiation given their developmental origin
have been isolated from different niches within the pulp
[25, 38, 40, 41]. A recent study compared the proliferative
and differentiation potentials of human DPSCs based on
the expression of the pericyte-associated cell surface antigen
CD34 [42]. Only CD34+ hDPSCs were found to express
nestin and possess the ability to differentiate down neu-
ronal lineages, similar to the high nestin-expressing mDPSC
described here, suggesting that they may be neural crest in
origin and derived from a perivascular-associated niche. It
may prove beneficial to select for suchDPSCs in future neural
tissue engineering studies.
Together, the results presented herein suggest that mRNA
levels of nestin may be indicative of the potential of mDP-
SCs for neuronal-like and oligodendrocyte-like differenti-
ation. Nestin expression is associated with stem cells in
the developing neural tube as well as specific subtypes of
OPCs [43, 44]. As such, its link to mDPSCs with neu-
ronal and oligodendrocyte-like differentiation capabilities
fits. However, nestin-positive cells make up only a small
fraction of the total cellular component of dental pulp,
less than 3.5% reported in isolates from rat incisors [45].
Most published studies utilise such mixed populations of
cells and so likely contain a significant proportion of other
cell types, perhaps explaining previous inconsistencies in
response to neuronal differentiation cues [18, 22]. The use of
clonally derived cultures allows investigations to be carried
out at the single cell level and the subsequent identification
of differences between individual clonal cell lines. Large
differences in the proliferation and mineralisation potential
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of clonal DPSC cultures have been previously reported in
this manner [1, 9]. Similarly, differences in the neuronal-like
and oligodendrocyte-like differentiation potential of mDPSC
clones are reported here.The use of single cell-derived clones
is unlikely to be therapeutically applicable due to scalability
issues within short time frames. However, clonal cultures
serve as an extremely useful research tool to identify desir-
able properties of cells within mixed populations. In future
studies, the screening of single cell-derived clones on a larger
scale to that described in this report will serve to further our
understanding of cellular heterogeneity and its implications
for the development of stem cell-based therapies.
5. Conclusions
Significant heterogeneity exists between clonal cultures of
mDPSCs and clones with comparatively higher levels of
nestin expression possess a greater capacity for differentiation
into neural lineages. These findings help explain previous
reports of only small numbers of transplanted DPSCs adopt-
ing neuronal-like and glial-like phenotypes after transplan-
tation, as well as inconsistencies in in vitro differentiation
studies. In conclusion, high nestin-expressing DPSCs may
represent a more desirable cell source for promoting central
nervous system repair and regeneration.
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